The appointment of a new interim CEO can have various impacts on a company's stock price. However, since Nicole Sandford will remain as a consultant to ensure a smooth transition, the immediate impact on the stock price is likely neutral. Investors may wait to see how Dr. Milligan's leadership affects the company's strategy and performance.